Conversion from cyclosporine to tacrolimus based immunosuppression thrapy in renal transplant recipients

被引：0
|
作者：
Backman, Lars A. [1 ]
机构：
[1] Sahlgrens Univ Hosp, Gothenburg, Sweden
来源：
TRANSPLANT INTERNATIONAL | 2007年 / 20卷
关键词：
D O I：
暂无
中图分类号：
R61 [外科手术学];
学科分类号：
摘要：
引用
收藏
页码：138 / 138
页数：1
相关论文
共 50 条
  • [21] Conversion from Tacrolimus to Cyclosporine A Improves Glucose Tolerance in HCV-Positive Renal Transplant Recipients
    Handisurya, Ammon
    Kerscher, Corinna
    Tura, Andrea
    Herkner, Harald
    Payer, Berit Anna
    Mandorfer, Mattias
    Werzowa, Johannes
    Winnicki, Wolfgang
    Reiberger, Thomas
    Kautzky-Willer, Alexandra
    Pacini, Giovanni
    Saeemann, Marcus
    Schmidt, Alice
    [J]. PLOS ONE, 2016, 11 (01):
  • [22] Conversion from cyclosporine a to tacrolimus has beneficial effects on blood pressure in longterm renal transplant recipients
    Hillebrand, U
    Gerhardt, U
    Suwelack, B
    [J]. AMERICAN JOURNAL OF HYPERTENSION, 2004, 17 (05) : 92A - 92A
  • [23] Conversion to a Belatacept Based Immunosuppression Regimen in Renal Transplant Recipients
    Paplaczyk, K.
    Cunningham, K.
    D'Agostino, C.
    Pinelli, D.
    Schulte, J.
    Shetty, A.
    [J]. AMERICAN JOURNAL OF TRANSPLANTATION, 2020, 20 : 439 - 440
  • [24] Tacrolimus, cyclosporine and plasma lipoproteins in renal transplant recipients
    Venkiteswaran, K
    Sgoutas, DS
    Santanam, N
    Neylan, JE
    [J]. TRANSPLANT INTERNATIONAL, 2001, 14 (06) : 405 - 410
  • [25] Conversion from cyclosporine to sirolimus in stable renal transplant recipients
    Sennesael, JJ
    Bosmans, JL
    Bogers, JP
    Verbeelen, D
    Verpooten, GA
    [J]. TRANSPLANTATION, 2005, 80 (11) : 1578 - 1585
  • [26] Gene expression of the renal endothelin system in renal transplant recipients on cyclosporine a based immunosuppression
    Åsberg, A
    Attramadal, H
    Midtvedt, K
    Sund, S
    Hartmann, A
    Berg, KJ
    [J]. TRANSPLANTATION, 1999, 67 (07) : 1056 - 1060
  • [27] Induction versus noninduction in renal transplant recipients with tacrolimus-based immunosuppression
    Mourad, G
    Garrigue, V
    Squifflet, JP
    Besse, T
    Berthoux, F
    Alamartine, E
    Durand, D
    Rostaing, L
    Lang, P
    Baron, C
    Glotz, D
    Antoine, C
    Vialtel, P
    Romanet, T
    Lebranchu, Y
    Al Najjar, A
    Hiesse, C
    Potaux, L
    Merville, P
    Touraine, JL
    Lefrancois, N
    Kessler, M
    Renoult, E
    Pouteil-Noble, C
    Cahen, R
    Legendre, C
    Bedrossian, J
    Le Pogamp, P
    Rivalan, J
    Olmer, M
    Purgus, R
    Mignon, F
    Viron, B
    Charpentier, B
    [J]. TRANSPLANTATION, 2001, 72 (06) : 1050 - 1055
  • [28] Conversion to tacrolimus immunosuppression in renal transplant recipients:: 12-month follow-up
    Citterio, F
    Scatà, MC
    Romagnoli, J
    Pozzetto, U
    Nanni, G
    Castagneto, M
    [J]. TRANSPLANTATION PROCEEDINGS, 2002, 34 (05) : 1685 - 1686
  • [29] Switching Immunosuppression From Cyclosporine to Tacrolimus in Kidney Transplant Recipients Based on CYP3A5 Genotyping
    Wang, Xuebin
    Yang, Yunyun
    Liu, Zhengyue
    Xiao, Chengwu
    Gao, Lihong
    Zhang, Wenjing
    Zhang, Wenwen
    Wang, Zhuo
    [J]. THERAPEUTIC DRUG MONITORING, 2019, 41 (01) : 97 - 101
  • [30] Conversion at first rejection: A prospective trial comparing cyclosporine microemulsion with tacrolimus in renal transplant recipients
    Dudley, CRK
    [J]. TRANSPLANTATION PROCEEDINGS, 2001, 33 (1-2) : 1034 - 1035
12345